ArticleScientific reports2022

Novel psoralen derivatives as anti-breast cancer agents and their light-activated cytotoxicity against HER2 positive breast cancer cells.

Chiphada Aekrungrueangkit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.